Literature DB >> 3087020

HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease.

B Jhinghan, N K Mehra, K S Reddy, V Taneja, M C Vaidya, M L Bhatia.   

Abstract

The distribution of HLA-A, -B and -DR antigens as well as blood groups and secretor status was studied in sporadic, North Indian patients of rheumatic fever and rheumatic heart disease. While HLA-Aw33 occurred with an increased frequency in the patient group (X2 = 4.01), no statistically significant differences were observed in the frequency of B-locus antigens. In the DR locus, HLA-DR3 was found to be significantly increased (50% vs 26.1%, X2 = 13.8) and DR2 significantly reduced (21.8% vs 47.0%, X2 = 15.6). Also, there was a preponderance of non-'O' blood group individuals in the patient group as compared to controls. The DR3 association was significant only in those patients of RHD who did not have any previous history of rheumatic fever. These results indicate that susceptibility to rheumatic heart disease is HLA-class II mediated, with HLA-DR3 influencing susceptibility and DR2 conferring protection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087020     DOI: 10.1111/j.1399-0039.1986.tb01517.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  Relationship between infectious diseases and human blood type.

Authors:  S A Berger; N A Young; S C Edberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

2.  Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.

Authors:  A K Khanna; D R Buskirk; R C Williams; A Gibofsky; M K Crow; A Menon; M Fotino; H M Reid; T Poon-King; P Rubinstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

4.  A genetic marker for rheumatic heart disease.

Authors:  C N Rajapakse; K Halim; I Al-Orainey; M Al-Nozha; A K Al-Aska
Journal:  Br Heart J       Date:  1987-12

5.  HLA and rheumatic fever in Turkish Children.

Authors:  H E Khosroshahi; O Kahramanyol; L Doğanci
Journal:  Pediatr Cardiol       Date:  1992-10       Impact factor: 1.655

6.  Rheumatic Fever.

Authors:  Ma Binotto; L Guilherme; Ac Tanaka
Journal:  Images Paediatr Cardiol       Date:  2002-04

7.  HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Ruta Shantere; Dace Gardovska
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia.

Authors:  Valda Stanevicha; Jelena Eglite; Arturs Sochnevs; Dace Gardovska; Dace Zavadska; Ruta Shantere
Journal:  Arthritis Res Ther       Date:  2003-09-08       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.